RxDoctor Payments Data

Shawn Storm, DO

Orthopaedic Surgery · Charleston, WVNPI 1568653475

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,749 of the $4,090 with a category attached, or 67.2%. 21 manufacturers reported payments, led by Zimmer Biomet at 43.1% of the total. Reporting peaked in 2021 at $1,371 and has fallen 86.8% since, to $181 in 2025.

$4,090in general payments, 2019–2025

Across 76 payments — averaging $53.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$2K
  • Stryker$403
  • Johnson & Johnson$368
  • Pacira Therapeutics, Inc.$307
  • Bioventus LLC$302
  • Medical Device Business Services, Inc.$293
  • plus $653 from 15 others

What the payments were for

  • Travel & lodging$1,34133%
  • Food & beverage$2,74967%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,090 in reported general payments places this provider in the 60th percentile of 93 orthopaedic surgery providers in West Virginia.

See all orthopaedic surgery providers in West Virginia

Medicare billing

Part B allowed, 2024
$16,348
Medicare patients
33
Services billed
487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam176$483

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →